Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification

[1]  Yiming Zhao,et al.  Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy , 2021, Frontiers in Surgery.

[2]  J. Bruix,et al.  BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.

[3]  T. Pawlik,et al.  Textbook outcomes in hepatobiliary and pancreatic surgery , 2021, World journal of gastroenterology.

[4]  S. Yerkovich,et al.  The impact of comorbidities on post-operative complications following colorectal cancer surgery , 2020, PloS one.

[5]  V. Shelat,et al.  Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma , 2020, Visceral Medicine.

[6]  I. Endo,et al.  Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria , 2020, Annals of Surgical Oncology.

[7]  I. Endo,et al.  Hepatocellular carcinoma tumour burden score to stratify prognosis after resection , 2020, The British journal of surgery.

[8]  I. Endo,et al.  Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  B. Koneru,et al.  The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization , 2019, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[10]  T. Pawlik,et al.  A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma. , 2019, JAMA surgery.

[11]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[12]  T. Riall,et al.  Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma , 2019, JAMA network open.

[13]  T. Pawlik,et al.  Textbook Outcomes Among Medicare Patients Undergoing Hepatopancreatic Surgery , 2018, Annals of surgery.

[14]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[15]  Rafael Duran,et al.  Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. , 2018, The lancet. Gastroenterology & hepatology.

[16]  S. Shrikhande,et al.  Liver resection for HCC outside the BCLC criteria , 2018, Langenbeck's Archives of Surgery.

[17]  S. Friedman,et al.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. , 2017, Journal of hepatology.

[18]  K. Nan,et al.  Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages , 2017, Cancer management and research.

[19]  Wei-Chen Lee,et al.  Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection , 2017, Journal of hepato-biliary-pancreatic sciences.

[20]  T. Pawlik,et al.  Trends in the Mortality of Hepatocellular Carcinoma in the United States , 2017, Journal of Gastrointestinal Surgery.

[21]  R. van Hillegersberg,et al.  Textbook outcome as a composite measure in oesophagogastric cancer surgery , 2017, The British journal of surgery.

[22]  H. Eguchi,et al.  Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma. , 2016, Surgery.

[23]  P. Rosenberg,et al.  Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Kievit,et al.  Focusing on desired outcomes of care after colon cancer resections; hospital variations in 'textbook outcome'. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  Shou-Dong Lee,et al.  Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? , 2012, Surgery.

[27]  Guang-shun Yang,et al.  Risk Factors Influencing Postoperative Outcomes of Major Hepatic Resection of Hepatocellular Carcinoma for Patients with Underlying Liver Diseases , 2011, World Journal of Surgery.

[28]  K. Markou,et al.  Complications and risk factors related to the extent of surgery in thyroidectomy. Results from 2,043 procedures , 2010, Hormones.

[29]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[30]  Alessandro Vitale,et al.  Prospective validation of the Barcelona Clinic Liver Cancer staging system. , 2006, Journal of hepatology.

[31]  S. Strasberg,et al.  Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. , 2005, Journal of hepato-biliary-pancreatic surgery.

[32]  J. Marrero,et al.  Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort , 2005, Hepatology.

[33]  I. Endo,et al.  The Tumor Burden Score: A New “Metro-ticket” Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors , 2018, Annals of surgery.

[34]  T. Pawlik,et al.  Epidemiology of hepatocellular carcinoma. , 2015, Surgical oncology clinics of North America.